Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Serotonin transporter gene associated with lithium prophylaxis in mood disorders

Abstract

The aim of this study was to investigate the possible association between the functional polymorphism in the upstream regulatory region of the serotonin transporter gene (5-HTTLPR) and the prophylactic efficacy of lithium in mood disorders. Two hundred and one subjects affected by bipolar (n = 167) and major depressive (n = 34) disorder were followed prospectively for an average of 58.2 months and were typed for their 5-HTTLPR variant using polymerase chain reaction techniques. 5-HTTLPR variants were associated with lithium outcome (F = 5.35; df = 2,198; P = 0.005). Subjects with the s/s variant showed a worse response compared to both l/s and l/l variants. Consideration of possible stratification effects such as sex, polarity, age at onset, duration of lithium treatment and previous episodes did not influence the observed association. 5-HTTLPR variants may be a possible influencing factor for the prophylactic efficacy of lithium in mood disorders.

This is a preview of subscription content

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

References

  1. Goodwin F, Jamison K . Manic-Depressive Illness Oxford University Press: New York 1990

    Google Scholar 

  2. Schou M . Lithium Treatment of Manic Depressive Illness. A Practical Guide Karger: Basel 1989

    Google Scholar 

  3. Maj M, Arena F, Lovero N, Pirozzi R, Kemali D . Factors associated with response to lithium prophylaxis in DSM III major depression and bipolar disorder Pharmacopsychiatry 1985 18: 309–313

    CAS  PubMed  Google Scholar 

  4. Maj M, Pirozzi R, Starace F . Previous pattern of course of the illness as a predictor of response to lithium prophylaxis in bipolar patients J Affect Disord 1989 17: 237–241

    CAS  PubMed  Google Scholar 

  5. OConnell RA, Mayo JA, Flatow L, Cuthbertson BO, Brien BE . Outcome of bipolar disorder on long-term treatment with lithium Br J Psychiatry 1991 159: 123–129

    CAS  Google Scholar 

  6. Abou-Saleh MT . Who responds to prophylactic lithium therapy? Br J Psychiatry 1993 (suppl 21): 20–26

    Google Scholar 

  7. Franchini L, Zanardi R, Smeraldi E, Gasperini M . Early onset of lithium prophylaxis as a predictor of good long-term outcome Eur Arch Psychiatry Clin Neurosci 1999 249: 227–230

    CAS  PubMed  Google Scholar 

  8. Serretti A, Lattuada E, Franchini L, Smeraldi E . Melancholic features and response to lithium prophylaxis in mood disorders Depress Anxiety 2000 11: 73–79

    CAS  PubMed  Google Scholar 

  9. Mendlewicz J, Fieve RR, Stallone F, Fleiss JL . Genetic history as a predictor of lithium response in manic-depressive illness Lancet 1972 1: 599–600

    CAS  PubMed  Google Scholar 

  10. Maj M, Del Vecchio M, Starace F, Pirozzi R, Kemali D . Prediction of affective psychoses response to lithium prophylaxis. The role of socio-demographic, clinical, psychological and biological variables Acta Psychiatr Scand 1984 69: 37–44

    CAS  PubMed  Google Scholar 

  11. Grof P, Alda M, Grof E, Zvolsky P, Walsh M . Lithium response and genetics of affective disorders J Affect Disord 1994 32: 85–95

    CAS  PubMed  Google Scholar 

  12. Morabito A, Gasperini M, Macciardi F, Smeraldi E . Possible relationship between outcome in primary affective disorders treated with lithium and family history Adv Biochem Psychopharmacol 1982 32: 157–163

    CAS  PubMed  Google Scholar 

  13. Smeraldi E, Petroccione A, Gasperini M, Macciardi F, Orsini A . The search for genetic homogeneity in affective disorders J Affect Disord 1984 7: 99–107

    CAS  PubMed  Google Scholar 

  14. Smeraldi E, Petroccione A, Gasperini M, Macciardi F, Orsini A, Kidd KK . Outcomes on lithium treatment as a tool for genetic studies in affective disorders J Affect Disord 1984 6: 139–151

    CAS  PubMed  Google Scholar 

  15. Cavazzoni P, Alda M, Turecki G, Rouleau G, Grof E, Gerlach JH et al . Lithium-responsive affective disorders: no association with the tyrosine hydroxylase gene Psychiatry Res 1996 64: 91–96

    CAS  PubMed  Google Scholar 

  16. Turecki G, Alda M, Grof P, Martin R, Cavazzoni PA, Gerlach JH et al . No association between chromosome-18 markers and lithium-responsive affective disorders Psychiatry Res 1996 63: 17–23

    CAS  PubMed  Google Scholar 

  17. Belmaker RH, Bersudsky Y, Agam G, Levine J, Kofman O . How does lithium work on manic depression? Clinical and psychological correlates of the inositol theory Annu Rev Med 1996 47: 47–56

    CAS  PubMed  Google Scholar 

  18. El-Mallakh S . Lithum: Actions and Mechanisms American Psychiatric Press: Washington, DC 1996

    Google Scholar 

  19. Benkelfat C . Serotoninergic mechanisms in psychiatric disorders: new research tools, new ideas Int Clin Psychopharmacol 1993 8 suppl: 53–56

    Google Scholar 

  20. Jacobs BL, Fornal CA . Serotonin and behavior. A general hypothesis. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: The Fourth Generation of Progress Raven Press: New York 1995 pp 461–469

    Google Scholar 

  21. Pei Q, Leslie RA, Grahame-Smith DG, Zetterstrom TS . 5-HT efflux from rat hippocampus in vivo produced by 4-aminopyridine is increased by chronic lithium administration Neuroreport 1995 6: 716–720

    CAS  PubMed  Google Scholar 

  22. Sharp T, Bramwell SR, Lambert P, Grahame-Smith DG . Effect of short- and long-term administration of lithium on the release of endogenous 5-HT in the hippocampus of the rat in vivo and in vitro Neuropharmacology 1991 30: 977–984

    CAS  PubMed  Google Scholar 

  23. Treiser SL, Cascio CS, O’Donohue TL, Thoa NB, Jacobowitz DM, Kellar KJ . Lithium increases serotonin release and decreases serotonin receptors in the hippocampus Science 1981 213: 1529–1531

    CAS  PubMed  Google Scholar 

  24. Baptista TJ, Hernandez L, Burguera JL, Burguera M, Hoebel BG . Chronic lithium administration enhances serotonin release in the lateral hypothalamus but not in the hippocampus in rats. A microdialysis study J Neural Transm Gen Sect 1990 82: 31–41

    CAS  PubMed  Google Scholar 

  25. Goodwin GM . The effects of antidepressant treatments and lithium upon 5-HT1A receptor function Prog Neuropsychopharmacol Biol Psychiatry 1989 13: 445–451

    CAS  PubMed  Google Scholar 

  26. Odagaki Y, Koyama T, Matsubara S, Matsubara R, Yamashita I . Effects of chronic lithium treatment on serotonin binding sites in rat brain J Psychiatr Res 1990 24: 271–277

    CAS  PubMed  Google Scholar 

  27. Carli M, Reader TA . Regulation of central serotonin transporters by chronic lithium: an autoradiographic study Synapse 1997 27: 83–89

    CAS  PubMed  Google Scholar 

  28. Carli M, Afkhami-Dastjerdian S, Reader TA . Effects of a chronic lithium treatment on cortical serotonin uptake sites and 5-HT1A receptors Neurochem Res 1997 22: 427–435

    CAS  PubMed  Google Scholar 

  29. Artigas F, Sarrias MJ, Martinez E, Gelpi E, Alvarez E, Udina C . Increased plasma free serotonin but unchanged platelet serotonin in bipolar patients treated chronically with lithium Psychopharmacology 1989 99: 328–332

    CAS  PubMed  Google Scholar 

  30. Price LH, Charney DS, Delgado PL, Heninger GR . Lithium treatment and serotoninergic function. Neuroendocrine and behavioral responses to intravenous tryptophan in affective disorder Arch Gen Psychiatry 1989 46: 13–19

    CAS  PubMed  Google Scholar 

  31. Hotta I, Yamawaki S, Segawa T . Long-term lithium treatment causes serotonin receptor down-regulation via serotonergic presynapses in rat brain Neuropsychobiology 1986 16: 19–26

    CAS  PubMed  Google Scholar 

  32. Cassidy F, Murry E, Carroll BJ . Tryptophan depletion in recently manic patients treated with lithium Biol Psychiatry 1998 43: 230–232

    CAS  PubMed  Google Scholar 

  33. Chaouloff F, Gunn SH, Young JB . Serotonin does not mediate the adrenal catecholamine-releasing effect of acute lithium administration in rats Psychoneuroendocrinology 1992 17: 135–144

    CAS  PubMed  Google Scholar 

  34. Lacaille JC, Cloutier S, Reader TA . Lithium reduced synaptic transmission and increased neuronal excitability without altering endogenous serotonin, norepinephrine and dopamine in rat hippocampal slices in vitro Prog Neuropsychopharmacol Biol Psychiatry 1992 16: 397–412

    CAS  PubMed  Google Scholar 

  35. Manji HK, Hsiao JK, Risby ED, Oliver J, Rudorfer MV, Potter WZ . The mechanisms of action of lithium. I. Effects on serotoninergic and noradrenergic systems in normal subjects Arch Gen Psychiatry 1991 48: 505–512

    CAS  PubMed  Google Scholar 

  36. Price LH, Charney DS, Delgado PL, Heninger GR . Lithium and serotonin function: implications for the serotonin hypothesis of depression Psychopharmacology 1990 100: 3–12

    CAS  PubMed  Google Scholar 

  37. Collier D, Stöber G, Li T, Heils A, Catalano M, Di Gerlach JH et al . A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders Mol Psychiatry 1996 1: 453–460

    CAS  PubMed  Google Scholar 

  38. Collier DA, Arranz MJ, Sham P, Battersby S, Vallada H, Gerlach JH et al . The serotonin transporter is a potential susceptibility factor for bipolar affective disorder Neuroreport 1996 7: 1675–1679

    CAS  PubMed  Google Scholar 

  39. Rees M, Norton N, Jones I, McCandless F, Scourfield J, Gerlach JH et al . Association studies of bipolar disorder at the human serotonin transporter gene (hSERT; 5HTT) Mol Psychiatry 1997 2: 398–402

    CAS  PubMed  Google Scholar 

  40. Bellivier F, Laplanche JL, Leboyer M, Feingold J, Bottos C, Gerlach JH et al . Serotonin transporter gene and manic depressive illness: an association study Biol Psychiatry 1997 41: 750–752

    CAS  PubMed  Google Scholar 

  41. Mendes de Oliveira JR, Otto PA, Vallada H, Lauriano V, Elkis H, Gerlach JH et al . Analysis of a novel functional polymorphism within the promoter region of the serotonin transporter gene (5-HTT) in Brazilian patients affected by bipolar disorder and schizophrenia Am J Med Gen 1998 81: 225–227

    CAS  Google Scholar 

  42. Furlong RA, Ho L, Walsh C, Rubinsztein JS, Jain S, Gerlach JH et al . Analysis and meta-analysis of two serotonin transporter gene polymorphisms in bipolar and unipolar affective disorders Am J Med Gen 1998 81: 58–63

    CAS  Google Scholar 

  43. Hoehe MR, Wendel B, Grunewald I, Chiaroni P, Levy N, Morris-Gerlach JH et al . Serotonin transporter (5-HTT) gene polymorphisms are not associated with susceptibility to mood disorders Am J Med Gen 1998 81: 1–3

    CAS  Google Scholar 

  44. Esterling LE, Yoshikawa T, Turner G, Badner JA, Bengel D, Gershon ES, Berrettini WH, Detera-Wadleigh SD . Serotonin transporter (5-HTT) gene and bipolar affective disorder Am J Med Gen 1998 81: 37–40

    CAS  Google Scholar 

  45. Gutierrez B, Arranz MJ, Collier DA, Valles V, Guillamat R, Gerlach JH et al . Serotonin transporter gene and risk for bipolar affective disorder—an association study in a Spanish population Biol Psychiatry 1998 43: 843–847

    CAS  PubMed  Google Scholar 

  46. Oruc L, Verheyen GR, Furac I, Jakovljevic M, Ivezic S, Gerlach JH et al . Association analysis of the 5-HT2C receptor and 5-HT transporter genes in bipolar disorder Am J Med Gen 1997 74: 504–506

    CAS  Google Scholar 

  47. Ewald H, Flint T, Degn B, Mors O, Kruse TA . A functional variant of the serotonin transporter gene in families with bipolar affective disorder J Affect Disord 1998 48: 135–144

    CAS  PubMed  Google Scholar 

  48. Kelsoe J, Remick R, Sadovnick A, Kristbjarnarson H, Flodman P, Gerlach JH et al . Genetic linkage study of bipolar disorder and the serotonin transporter Am J Med Gen 1996 67: 215–217

    CAS  Google Scholar 

  49. Lenzinger E, Neumeister A, Praschak-Rieder N, Fuchs K, Gerhard E, Gerlach JH et al . Behavioral effects of tryptophan depletion in seasonal affective disorder associated with the serotonin transporter gene? Psychiatry Res 1999 85: 241–246

    CAS  PubMed  Google Scholar 

  50. Mundo E, Walker M, Tims H, Macciardi F, Kennedy JL . Lack of linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and bipolar disorder Am J Med Genet 2000 96: 379–383

    CAS  PubMed  Google Scholar 

  51. Ospina-Duque J, Duque C, Carvajal-Carmona L, Ortiz-Barrientos D, Soto I, Gerlach JH et al . An association study of bipolar mood disorder (type I) with the 5-HTTLPR serotonin transporter polymorphism in a human population isolate from Colombia Neurosci Lett 2000 292: 199–202

    CAS  PubMed  Google Scholar 

  52. Saleem Q, Ganesh S, Vijaykumar M, Reddy YC, Brahmachari SK, Jain S . Association analysis of 5HT transporter gene in bipolar disorder in the Indian population Am J Med Genet 2000 96: 170–172

    CAS  PubMed  Google Scholar 

  53. Lesch K, Bengel D, Heils A, Sabol S, Greenberg B, Gerlach JH et al . Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region Science 1996 274: 1527–1530

    CAS  PubMed  Google Scholar 

  54. Jorm AF, Prior M, Sanson A, Smart D, Zhang Y, Easteal S . Association of a functional polymorphism of the serotonin transporter gene with anxiety-related temperament and behavior problems in children: a longitudinal study from infancy to the mid-teens Mol Psychiatry 2000 5: 542–547

    CAS  PubMed  Google Scholar 

  55. Greenberg BD, Li Q, Lucas FR, Hu S, Sirota LA, Gerlach JH et al . Association between the serotonin transporter promoter polymorphism and personality traits in a primarily female population sample Am J Med Genet 2000 96: 202–216

    CAS  PubMed  Google Scholar 

  56. Gustavsson JP, Nothen MM, Jonsson EG, Neidt H, Forslund K, Gerlach JH et al . No association between serotonin transporter gene polymorphisms and personality traits Am J Med Genet 1999 88: 430–436

    CAS  PubMed  Google Scholar 

  57. Kumakiri C, Kodama K, Shimizu E, Yamanouchi N, Okada S, Gerlach JH et al . Study of the association between the serotonin transporter gene regulatory region polymorphism and personality traits in a Japanese population Neuroscience Lett 1999 263: 205–207

    CAS  Google Scholar 

  58. Katsuragi S, Kunugi H, Sano A, Tsutsumi T, Isogawa K, Gerlach JH et al . Association between serotonin transporter gene polymorphism and anxiety-related traits Biol Psychiatry 1999 45: 368–370

    CAS  PubMed  Google Scholar 

  59. Murakami F, Shimomura T, Kotani K, Ikawa S, Nanba E, Adachi K . Anxiety traits associated with a polymorphism in the serotonin transporter gene regulatory region in the Japanese J Hum Genet 1999 44: 15–17

    CAS  PubMed  Google Scholar 

  60. Serretti A, Cusin C, Lattuada E, Di Bella D, Catalano M, Smeraldi E . Serotonin transporter gene (5-HTTLPR) is not associated with depressive symptomatology in mood disorders Mol Psychiatry 1999 4: 280–283

    CAS  Google Scholar 

  61. Rosenthal N, Mazzanti C, Barnett R, Hardin T, Turner E, Gerlach JH et al . Role of serotonin transporter promoter repeat length polymorphism (5-HTTLPR) in seasonality and seasonal affective disorder Mol Psychiatry 1998 3: 175–177

    CAS  PubMed  Google Scholar 

  62. Ohara K, Nagai M, Suzuki Y, Ochiai M . Association between anxiety disorders and a functional polymorphism in the serotonin transporter gene Psychiatry Res 1998 81: 277–279

    CAS  PubMed  Google Scholar 

  63. Klauck SM, Poustka F, Benner A, Lesch KP, Poustka A . Serotonin transporter (5-HTT) gene variants associated with autism? Hum Mol Genet 1997 6: 2233–2238

    CAS  PubMed  Google Scholar 

  64. Cook EH Jr, Courchesne R, Lord C, Cox NJ, Yan S, Gerlach JH et al . Evidence of linkage between the serotonin transporter and autistic disorder Mol Psychiatry 1997 2: 247–250

    PubMed  Google Scholar 

  65. Persico AM, Militerni R, Bravaccio C, Schneider C, Melmed R, Gerlach JH et al . Lack of association between serotonin transporter gene promoter variants and autistic disorder in two ethnically distinct samples Am J Med Genet 2000 96: 123–127

    CAS  PubMed  Google Scholar 

  66. Ohara K, Suzuki Y, Ochiai M, Tsukamoto T, Tani K . A variable-number-tandem-repeat of the serotonin transporter gene and anxiety disorders Prog Neuropsychopharmacol Biol Psychiatry 1999 23: 55–65

    CAS  PubMed  Google Scholar 

  67. Hamilton SP, Heiman GA, Haghighi F, Mick S, Klein DF, Gerlach JH et al . Lack of genetic linkage or association between a functional serotonin transporter polymorphism and panic disorder Psychiatr Genet 1999 9: 1–6

    CAS  PubMed  Google Scholar 

  68. Sander T, Harms H, Lesch KP, Dufeu P, Kuhn S, Gerlach JH et al . Association analysis of a regulatory variation of the serotonin transporter gene with severe alcohol dependence Alcohol Clin Exp Res 1997 21: 1356–1359

    CAS  PubMed  Google Scholar 

  69. Hammoumi S, Payen A, Favre JD, Balmes JL, Benard JY, Gerlach JH et al . Does the short variant of the serotonin transporter linked polymorphic region constitute a marker of alcohol dependence? Alcohol 1999 17: 107–112

    CAS  PubMed  Google Scholar 

  70. Bellivier F, Szoke A, Henry C, Lacoste J, Bottos C, Nosten-Gerlach JH et al . Possible association between serotonin transporter gene polymorphism and violent suicidal behavior in mood disorders Biol Psychiatry 2000 48: 319–322

    CAS  PubMed  Google Scholar 

  71. Gorwood P, Batel P, Ades J, Hamon M, Boni C . Serotonin transporter gene polymorphisms, alcoholism, and suicidal behavior Biol Psychiatry 2000 48: 259–264

    CAS  PubMed  Google Scholar 

  72. Geijer T, Frisch A, Persson ML, Wasserman D, Rockah R, Gerlach JH et al . Search for association between suicide attempt and serotonergic polymorphisms Psychiatr Genet 2000 10: 19–26

    CAS  PubMed  Google Scholar 

  73. Bligh-Glover W, Kolli TN, Shapiro-Kulnane L, Dilley GE, Friedman L, Gerlach JH et al . The serotonin transporter in the midbrain of suicide victims with major depression Biol Psychiatry 2000 47: 1015–1024

    CAS  PubMed  Google Scholar 

  74. Malhotra AK, Goldman D, Mazzanti C, Clifton A, Breier A, Pickar D . A functional serotonin transporter (5-HTT) polymorphism is associated with psychosis in neuroleptic-free schizophrenics Mol Psychiatry 1998 3: 328–332

    CAS  PubMed  Google Scholar 

  75. Bonnet-Brilhault F, Laurent C, Thibaut F, Campion D, Chavand O, Gerlach JH et al . Serotonin transporter gene polymorphism and schizophrenia: an association study Biol Psychiatry 1997 42: 634–636

    CAS  PubMed  Google Scholar 

  76. Stober G, Jatzke S, Heils A, Jungkunz G, Fuchs E, Gerlach JH et al . Susceptibility for schizophrenia is not influenced by a functional insertion/deletion variant in the promoter of the serotonin transporter gene Eur Arch Psychiatry Clin Neurosci 1998 248: 82–86

    CAS  PubMed  Google Scholar 

  77. Naylor L, Dean B, Pereira A, Mackinnon A, Kouzmenko A, Copolov D . No association between the serotonin transporter-linked promoter region polymorphism and either schizophrenia or density of the serotonin transporter in human hippocampus Molec Med 1998 4: 671–674

    CAS  Google Scholar 

  78. Rao D, Jonsson E, Paus S, Ganguli R, Nothen M, Nimgaonkar V . Schizophrenia and the serotonin transporter gene Psychiatr Genet 1998 8: 207–212

    CAS  PubMed  Google Scholar 

  79. Hranilovic D, Schwab SG, Jernej B, Knapp M, Lerer B, Gerlach JH et al . Serotonin transporter gene and schizophrenia: evidence for association/linkage disequilibrium in families with affected siblings Mol Psychiatry 2000 5: 91–95

    CAS  PubMed  Google Scholar 

  80. Tsai SJ, Hong CJ, Yu YW, Lin CH, Song HL, Gerlach JH et al . Association study of a functional serotonin transporter gene polymorphism with schizophrenia, psychopathology and clozapine response Schizophr Res 2000 44: 177–181

    CAS  PubMed  Google Scholar 

  81. Serretti A, Lattuada E, Catalano M, Smeraldi E . Serotonin transporter gene not associated with psychotic symptomatology of mood disorders Psychiatry Res 1999 86: 59–65

    CAS  PubMed  Google Scholar 

  82. Serretti A, Catalano M, Smeraldi E . Serotonin transporter gene is not associated with symptomatology of schizophrenia Schizophr Res 1999 35: 33–39

    CAS  PubMed  Google Scholar 

  83. Heils A, Teufel A, Petri S, Stöber G, Riederer P, Gerlach JH et al . Allelic variation of human serotonin transporter gene expression J Neurochem 1996 66: 2621–2624

    CAS  PubMed  Google Scholar 

  84. Lipp O, Mahieu B, Souery D, Serretti A, Cavallini C, Gerlach JH et al . Molecular genetics of bipolar disorders: implication for psychotropic drugs. Xth Congress of the European College of Neuropsychopharmacology 1997, Vienna, Austria

  85. Serretti A, Lilli R, Lorenzi C, Gasperini M, Smeraldi E . Tryptophan hydroxylase gene and response to lithium prophylaxis in mood disorders J Psychiatr Res 1999 33: 371–377

    CAS  PubMed  Google Scholar 

  86. Serretti A, Lilli R, Lorenzi C, Franchini L, DiBella D, Gerlach JH et al . Dopamine receptor D2, D4, GABAA alpha-1 subunit genes and response to lithium prophylaxis in mood disorders Psychiatry Res 1999 87: 7–19

    CAS  PubMed  Google Scholar 

  87. Serretti A, Lilli R, Lorenzi C, Gasperini M, Smeraldi E . Dopamine receptor D3 gene and response to lithium prophylaxis in mood disorders Int J Neuropsychopharmacol 1998 1: 125–129

    PubMed  Google Scholar 

  88. Serretti A, Lorenzi C, Lilli R, Smeraldi E . Serotonin receptor 2A, 2C, 1A genes and response to lithium prophylaxis in mood disorders J Psychiatr Res 2000 34: 89–98

    CAS  PubMed  Google Scholar 

  89. Smeraldi E, Zanardi R, Benedetti F, Dibella D, Perez J, Catalano M . Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine Mol Psychiatry 1998 3: 508–511

    CAS  PubMed  Google Scholar 

  90. Zanardi R, Serretti A, Rossini D, Franchini L, Cusin C, Gerlach JH et al . Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression Biol Psychiatry (in press)

  91. Zanardi R, Benedetti F, DiBella D, Catalano M, Smeraldi E . Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of serotonin transporter gene J Clin Psychopharmacol 2000 20: 105–107

    CAS  PubMed  Google Scholar 

  92. Pollock BG, Ferrell RE, Mulsant BH, Mazumdar S, Miller M, Gerlach JH et al . Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression Neuropsychopharmacology 2000 23: 587–590

    CAS  PubMed  Google Scholar 

  93. Benedetti F, Serretti A, Colombo C, Campori E, Barbini B, Di Gerlach JH et al . Influence of a functional polymorphism within the promoter of the serotonin transporter gene on the effects of total sleep deprivation in bipolar depression Am J Psychiatry 1999 156: 1450–1452

    CAS  PubMed  Google Scholar 

  94. Greenberg BD, Tolliver TJ, Huang SJ, Li Q, Bengel D, Murphy DL . Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets Am J Med Gen 1999 88: 83–87

    CAS  Google Scholar 

  95. Bellivier F, Henry C, Szoke A, Schurhoff F, Nosten-Bertrand M, Gerlach JH et al . Serotonin transporter gene polymorphisms in patients with unipolar or bipolar depression Neurosci Lett 1998 255: 143–146

    CAS  PubMed  Google Scholar 

  96. Flory JD, Manuck SB, Ferrell RE, Dent KM, Peters DG, Muldoon MF . Neuroticism is not associated with the serotonin transporter (5-HTTLPR) polymorphism Mol Psychiatry 1999 4: 93–96

    CAS  PubMed  Google Scholar 

  97. Matsushita S, Muramatsu T, Kimura M, Shirakawa O, Mita T, Gerlach JH et al . Serotonin transporter gene regulatory region polymorphism and panic disorder Mol Psychiatry 1997 2: 390–392

    CAS  PubMed  Google Scholar 

  98. Fuciarelli M, Vienna A, Paba E, Bastianini A, Sansonetti B, Capucci E et l . PI, GC, HP, and TF serum protein polymorphisms in Siena, Tuscany, Italy, with a review of data for Italy Am J Hum Biol 1997 9: 629–646

    PubMed  Google Scholar 

  99. Maj M, Pirozzi R, Magliano L, Bartoli L . Long-term outcome of lithium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients at a lithium clinic Am J Psychiatry 1998 155: 30–35

    CAS  PubMed  Google Scholar 

  100. Lattuada E, Serretti A, Cusin C, Gasperini M, Macciardi F, Smeraldi E . Symptomatologic analysis of psychotic and non-psychotic depression J Affect Disord 1999 54: 183–187

    CAS  PubMed  Google Scholar 

  101. Serretti A, Lattuada E, Cusin C, Gasperini M, Smeraldi E . Clinical and demographical features of psychotic and nonpsychotic depression Compr Psychiatry 1999 40: 358–362

    CAS  PubMed  Google Scholar 

  102. Cohen J . Statistical Power Analysis for the Behavioral Sciences Lawrence Erlbaum Associates: Hillsdale, New Jersey 1988

    Google Scholar 

  103. Risch N, Botstein D . A manic depressive history Nat Genet 1996 12: 351–353

    CAS  PubMed  Google Scholar 

  104. Tsuang M, Faraone S . The Genetics of Mood Disorders The Johns Hopkins University Press: Baltimore 1990

    Google Scholar 

  105. Muller-Oerlinghausen B . Does effective lithium prophylaxis result in a symptom-free state of manic-depressive illness? Some thoughts on the fine-tuning of mood stabilization Compr Psychiatry 2000 41: 26–31

    CAS  PubMed  Google Scholar 

  106. Page C, Benaim S, Lappin F . A long-term retrospective follow-up study of patients treated with prophylactic lithium carbonate Br J Psychiatry 1987 150: 175–179

    CAS  PubMed  Google Scholar 

  107. Vestergaard P, Licht RW, Brodersen A, Rasmussen NA, Christensen H, Gerlach JH et al . Outcome of lithium prophylaxis—a prospective follow-up of affective disorder patients assigned to high and low serum lithium levels Acta Psychiatr Scand 1998 98: 310–315

    CAS  PubMed  Google Scholar 

  108. Kulhara P, Basu D, Mattoo SK, Sharan P, Chopra R . Lithium prophylaxis of recurrent bipolar affective disorder: long-term outcome and its psychosocial correlates J Affect Disord 1999 54: 87–96

    CAS  PubMed  Google Scholar 

  109. Tondo L, Baldessarini RJ, Hennen J, Floris G . Lithium maintenance treatment of depression and mania in bipolar I and bipolar II disorders Am J Psychiatry 1998 155: 638–645

    CAS  PubMed  Google Scholar 

  110. Baldessarini RJ, Tondo L . Does lithium treatment still work? Evidence of stable responses over three decades Arch Gen Psychiatry 2000 57: 187–190

    CAS  PubMed  Google Scholar 

  111. Souery D, Lipp O, Serretti A, Mahieu B, Rivelli SK, Gerlach JH et al . European Collaborative Project on Affective Disorders: Interactions between genetic and psychosocial vulnerability factors Psychiatr Genet 1998 8: 197–205

    CAS  PubMed  Google Scholar 

  112. Endicott J, Spitzer R . A diagnostic interview: the schedule for affective disorders and schizophrenia Arch Gen Psychiatry 1978 35: 837–844

    CAS  PubMed  Google Scholar 

  113. McGuffin P, Farmer A, Harvey I . A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system Arch Gen Psychiatry 1991 48: 764–770

    CAS  PubMed  Google Scholar 

  114. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders, 4th edn American Psychiatric Association: Washington DC 1994

    Google Scholar 

  115. Leckman JF, Sholomskas D, Thompson WD, Belanger A, Weissman MM . Best estimate of lifetime psychiatric diagnosis: a methodological study Arch Gen Psychiatry 1982 39: 879–883

    CAS  PubMed  Google Scholar 

  116. Hamilton M . Development of a rating scale for primary depressive illness Br J Soc Clin Psychol 1967 6: 278–296

    CAS  PubMed  Google Scholar 

  117. Young R, Biggs J, Ziegler V, Meyer D . A rating scale for mania: reliability, validity and sensitivity Br J Psychiatry 1978 133: 429–435

    CAS  PubMed  Google Scholar 

  118. Frank E, Prien RF, Jarrett RB, Keller MB, Kupfer DJ, Gerlach JH et al . Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence Arch Gen Psychiatry 1991 48: 851–855

    CAS  PubMed  Google Scholar 

  119. American Psychiatric Association . Practice guideline for the treatment of patients with bipolar disorder Am J Psychiatry 1994 151: 1–36

    Google Scholar 

  120. WMA . World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects JAMA 1997 277: 925–926

    Google Scholar 

  121. Gasperini M, Scherillo P, Manfredonia M, Franchini L, Smeraldi E . A study of relapses in subjects with mood disorder on lithium treatment Eur Neuropsychopharmacol 1993 3: 103–110

    CAS  PubMed  Google Scholar 

  122. Franchini L, Gasperini M, Smeraldi E . A 24-month follow-up study of unipolar subjects: a comparison between lithium and fluvoxamine J Affect Disord 1994 32: 225–231

    CAS  PubMed  Google Scholar 

  123. Lahiri DK, Nurnberger JIJ . A rapid non-enzimatic method for the preparation of HMW DNA from blood for RFLP studies Nucleic Acid Res 1991 19: 5444

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to E Smeraldi.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Serretti, A., Lilli, R., Mandelli, L. et al. Serotonin transporter gene associated with lithium prophylaxis in mood disorders. Pharmacogenomics J 1, 71–77 (2001). https://doi.org/10.1038/sj.tpj.6500006

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.tpj.6500006

Keywords

  • lithium
  • bipolar disorder
  • follow-up studies
  • pharmacogenetics

Further reading

Search

Quick links